EXPRES2ION BIOTECHNOLOGIES ApS: Financial statements 2016
CVR: 32770487
Source: annual report 2016, Danish Business Authority
01/01/2016 – 31/12/2016
EXPRES2ION BIOTECHNOLOGIES ApS (CVR 32770487) has filed annual accounts for 2016. In 2016, the company reported a gross profit of DKK -493,626 and a net result of DKK -7,120,464 compared with DKK -6,744,584 the year before. Equity in the 2016 report amounted to DKK 550,553. The solvency ratio was 7.3%. The company had 9 employees in the financial year.
- Gross Profit
- DKK -493,626
- Profit/Loss
- DKK -7,120,464
- Equity
- DKK 550,553
- Total Assets
- DKK 7,580,178
- Employees
- 9
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2016 | - | -494 t. | -7.1 mio. | 551 t. | 9 |
| 2015 | - | -2.2 mio. | -6.7 mio. | -4.9 mio. | - |
| 2014 | - | 5.3 mio. | 226 t. | 1.8 mio. | - |
| 2013 | - | 5.7 mio. | 585 t. | 1.6 mio. | - |
| 2012 | - | 1.6 mio. | -1.8 mio. | 1 mio. | - |
Official annual report
Find more companies like EXPRES2ION BIOTECHNOLOGIES ApS
Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.
Try the lead list generatorEvents in 2016
As of December 1, 2016, Charlotte Dyring has left the board of directors of EXPRES2ION BIOTECHNOLOGIES ApS.
EXPRES2ION BIOTECHNOLOGIES ApS has published its annual report for 2015. Gross profit came to DKK -2,240,109, and the net result was DKK -6,744,584.
As of May 24, 2016, Charlotte Dyring has joined the board of directors of EXPRES2ION BIOTECHNOLOGIES ApS.
As of May 24, 2016, Gitte Laurette Pedersen-Botero has joined the board of directors of EXPRES2ION BIOTECHNOLOGIES ApS.
As of May 24, 2016, Alexander R Duncan has left the board of directors of EXPRES2ION BIOTECHNOLOGIES ApS.
As of May 24, 2016, Charlotte Dyring has stepped down as director of EXPRES2ION BIOTECHNOLOGIES ApS.
As of May 3, 2016, is registered as an owner of EXPRES2ION BIOTECHNOLOGIES ApS with an ownership share of 100%.
As of April 1, 2016, Steen Søren Klysner is registered as adm. dir. of EXPRES2ION BIOTECHNOLOGIES ApS.
About EXPRES2ION BIOTECHNOLOGIES ApS
EXPRES2ION BIOTECHNOLOGIES ApS is a Danish company of the type Anpartsselskab based in Hørsholm, founded in 2010. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named ApS KBURS 17 NR. 6965. The management consists of Bent Ulrich Frandsen. The board consists of Martin Roland Jensen (chair), Jakob Ole Knudsen, Karin Garre and Michel Jean Baijot. The company is owned by Expres2ion Biotech Holding AB. The company has 19 employees (2026). In 2025, the company reported a gross profit of DKK -9,158,236 and a net result of DKK -21,948,253 compared with DKK -19,830,535 the year before. Equity in the 2025 report amounted to DKK 23,950,262.